A Prospective Observational Case Series of a Four-ring-haptic Acrylic One-piece IOL

NCT ID: NCT01244373

Last Updated: 2010-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To describe biocompatibility, postoperative results and complications after implantation of the Corneal Quatrix Evolutive (Corneal, Croma, Austria) intraocular lens, a hydrophilic acrylic intraocular lens (IOL) with 4-haptic design and 360° sharp optic edge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this prospective case series the Corneal Quatrix Evolutive IOL was implanted in 14 eyes of nine patients with senile cortico-nuclear cataract. A standardized surgical technique and post-operative regimen were applied. Six months postoperatively best corrected visual acuity (BCVA), refraction and complications (especially) posterior capsule opacification (PCO) were analysed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Best-corrected visual acuity posterior capsule opacification QUATRIX® Aspheric Evolutive pre-loaded

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with senile cataract

Patients with senile cataract

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with senile cortico-nuclear cataracts without previous intraocular surgery

Exclusion Criteria

* Dilated pupil size of \< 6 mm
* long-term anti-inflammatory treatment
* previous history of intraocular surgery
* previous history of corneal endothelial damage
* previous history of ocular trauma
* traumatic cataract
* history of uveitis
* diabetic retinopathy
* advanced macular degeneration
Minimum Eligible Age

50 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Department of ophthalmology, General Hospital Linz

UNKNOWN

Sponsor Role collaborator

General Hospital Linz

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of ophthalmology, General Hospital Linz

Linz, Upper Austria, Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Kramer S, Schroder AC, Bruckner K, Jonescu-Cuypers C, Seitz B. [Subluxation of hydrophilic acrylate intraocular lenses due to massive capsular fibrosis]. Ophthalmologe. 2010 May;107(5):460-4. doi: 10.1007/s00347-009-2025-y. German.

Reference Type BACKGROUND
PMID: 19756637 (View on PubMed)

Michael K, O'Colmain U, Vallance JH, Cormack TG. Capsule contraction syndrome with haptic deformation and flexion. J Cataract Refract Surg. 2010 Apr;36(4):686-9. doi: 10.1016/j.jcrs.2009.09.042.

Reference Type BACKGROUND
PMID: 20362866 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Quatrix01

Identifier Type: -

Identifier Source: org_study_id